Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 91 results:
Author Title Type [ Year] Filters: Author is Giannakoulas, George [Clear All Filters]
Epidemiology and initial management of pulmonary arterial hypertension: real-world data from the Hellenic pulmOnary hyPertension rEgistry (HOPE)..
Pulm Circ. 9(3), 2045894019877157.
(2019). Flaws in Anticoagulation Strategies in Patients With Atrial Fibrillation at Hospital Discharge..
J Cardiovasc Pharmacol Ther. 24(3), 225-232.
(2019). A gut feeling about children's exposure to hypertensive disorders of pregnancy in utero..
Eur J Prev Cardiol. 2047487319857213.
(2019). Hospitalisations for heart failure predict mortality in pulmonary hypertension related to congenital heart disease..
Heart. 105(6), 465-469.
(2019). Hospitalization affects the anticoagulation patterns of patients with atrial fibrillation..
J Thromb Thrombolysis. 48(2), 225-232.
(2019). How to evaluate patients with congenital heart disease-related pulmonary arterial hypertension..
Expert Rev Cardiovasc Ther. 17(1), 11-18.
(2019). Low-density lipoprotein cholesterol target value attainment based on 2019 ESC/EAS guidelines and lipid-lowering therapy titration for patients with acute coronary syndrome..
Eur J Prev Cardiol. 2047487319891780.
(2019). Management of iron deficiency in chronic heart failure: Practical considerations for clinical use and future directions..
Eur J Intern Med. 65, 17-25.
(2019). Motivational interviewing to support LDL-C therapeutic goals and lipid-lowering therapy compliance in patients with acute coronary syndromes (IDEAL-LDL) study: rationale and design..
Hellenic J Cardiol. 60(4), 249-253.
(2019). Practical Recommendations for the Diagnosis and Medical Management of Stable Angina: An Expert Panel Consensus..
J Cardiovasc Pharmacol. 74(4), 308-314.
(2019). A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus..
Int J Cardiol. 297, 83-90.
(2019). Pregnancy still contraindicated in pulmonary arterial hypertension related to congenital heart disease: True or false?.
Eur J Prev Cardiol. 26(10), 1064-1066.
(2019). Pulmonary Arterial Hypertension in Connective Tissue Disorders: The emerging role of screening and early diagnosis. A position paper for Greek Rheumatologists..
Mediterr J Rheumatol. 30(2), 90-93.
(2019). Pulmonary arterial hypertension: the case for a bioelectronic treatment..
Bioelectron Med. 5, 20.
(2019). Strength training in congenital heart disease: A way to boost respiratory function?.
Eur J Prev Cardiol. 26(5), 489-491.
(2019).
(2019). Acquired cardiovascular disease in adult patients with congenital heart disease..
Heart. 104(7), 546-547.
(2018). Balloon atrial septostomy in severe precapillary pulmonary hypertension: A single-center experience..
Hellenic J Cardiol.
(2018). A case of sarcoidosis-associated pulmonary hypertension masquerading as chronic thromboembolic pulmonary hypertension.
Pulmonary Circulation. 85733(3), 204589401876828.
(2018). A case of sarcoidosis-associated pulmonary hypertension masquerading as chronic thromboembolic pulmonary hypertension..
Pulm Circ. 8(3), 2045894018768289.
(2018). Definition and Management of Segmental Pulmonary Hypertension..
J Am Heart Assoc. 7(14),
(2018). Direct Oral Anticoagulants in Nonvalvular Atrial Fibrillation: Practical Considerations on the Choice of Agent and Dosing..
Cardiology. 140(2), 126-132.
(2018). Larissa Heart Failure Risk Score: a proposed simple score for risk stratification in chronic heart failure.
European Journal of Heart Failure. 206523014311334167121082526184050(3), 614 - 616.
(2018). Larissa Heart Failure Risk Score: a proposed simple score for risk stratification in chronic heart failure..
Eur J Heart Fail. 20(3), 614-616.
(2018). Overview of Systematic Reviews of Non-Vitamin K Oral Anticoagulants in Atrial Fibrillation..
Circ Cardiovasc Qual Outcomes. 11(12), e004769.
(2018).